FDA Grants Approval for Dicyclomine Hydrochloride ANDA216515
The FDA has granted approval for the ANDA216515 application for Dicyclomine Hydrochloride submitted by Rubicon Research.
Therapeutic Area
Therapeutic area intelligence for Antispasmodic with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.